2023-08-30 11:33 | CC:PSYB | Psybio Therapeutics Corp | 0.015 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-30 11:32 | CC:PSYB | Psybio Therapeutics Corp | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-21 10:26 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | News Release200 | Psybio gets green light from gov't to make tryptamines |
2023-05-30 16:41 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-30 16:33 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-04-28 17:13 | CC:PSYB | Psybio Therapeutics Corp | 0.035 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-04-28 17:04 | CC:PSYB | Psybio Therapeutics Corp | 0.035 | SEDAR MD & A815 | SEDAR MD & A |
2023-04-20 18:39 | CC:PSYB | Psybio Therapeutics Corp | 0.04 | News Release200 | Psybio closes third tranche of private placement |
2023-01-18 20:19 | CC:PSYB | Psybio Therapeutics Corp | 0.10 | Private Placement250 | Psybio Therapeutics 18,199,747-share private placement |
2023-01-13 18:13 | CC:PSYB | Psybio Therapeutics Corp | 0.07 | News Release200 | Psybio closes $276,689 second tranche private placement |
2023-01-10 13:00 | CC:PSYB | Psybio Therapeutics Corp | 0.08 | News Release200 | Psybio Therapeutics appoints Wisenberg as director |
2023-01-05 10:41 | CC:PSYB | Psybio Therapeutics Corp | | News Release200 | Psybio completes $633,281 1st tranche of financing |
2022-12-08 10:05 | CC:PSYB | Psybio Therapeutics Corp | 0.08 | News Release200 | Psybio files three U.S. patent applications |
2022-12-06 12:08 | CC:PSYB | Psybio Therapeutics Corp | 0.065 | News Release200 | Psybio files four U.S. PCT patent applications |
2022-12-01 12:12 | CC:PSYB | Psybio Therapeutics Corp | 0.07 | News Release200 | Psybio Therapeutics arranges $1M private placement |
2022-11-29 13:04 | CC:PSYB | Psybio Therapeutics Corp | 0.06 | News Release200 | Psybio files Q3 2022 results, talks patent filings |
2022-11-29 09:12 | CC:PSYB | Psybio Therapeutics Corp | 0.06 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-11-29 09:12 | CC:PSYB | Psybio Therapeutics Corp | 0.06 | SEDAR MD & A815 | SEDAR MD & A |
2022-10-11 10:30 | CC:PSYB | Psybio Therapeutics Corp | 0.125 | News Release200 | Psybio reaches agreement for psilocybin clinical trial |